Comments

Cabaletta Bio Stock Price, Quotes and Forecasts

Q: What sector and industry does Cabaletta Bio (CABA) operate in?

Cabaletta Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CABANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.98

0.073.66%

Pre-Market: 7:56 PM EDT

Cabaletta Bio (CABA) Forecast

News Earnings Cabaletta Bio (CABA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Cabaletta Bio Stock Price, Quotes and Forecasts | NASDAQ:CABA | Benzinga

Explore Cabaletta Bio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CABA.

Open	-
Close	-
Volume / Avg.	0 / 1.33M
Day Range	- - -
52 Wk Range	1.59 - 21.24
Market Cap	$96.78M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	14.29%
Days to Cover	4.17

Recent News

This C3.ai Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday

Avi Kapoor

US Stocks Likely To Open In The Green To End November On A High: Are Markets Set For A Santa Claus Rally In December? Analysts Decode

U.S. stock futures advanced on Friday after a day's break for Thanksgiving as investors look to end November on a high note.

Rishabh Mishra

Caballeta Bio Shares Surge The Most In 23 Months In A Single Day As It Unveils Plan To Meet FDA By 2025 For Systemic Sclerosis Drug Trial

Rishabh Mishra

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 1.33M
Day Range	- - -
52 Wk Range	1.59 - 21.24
Market Cap	$96.78M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	14.29%
Days to Cover	4.17

About Cabaletta Bio Inc

Sector

Health Care

Industry

Biotechnology

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cabaletta Bio (CABA) stock?

You can purchase shares of Cabaletta Bio (NASDAQ:CABA) through any online brokerage.

View our list of the best stock brokerages

Who are Cabaletta Bio (CABA) competitors?

Other companies in Cabaletta Bio’s space includes: Anixa Biosciences (NASDAQ:ANIX), Skye Bioscience (NASDAQ:SKYE), Adverum Biotechnologies (NASDAQ:ADVM), Atossa Therapeutics (NASDAQ:ATOS) and TScan Therapeutics (NASDAQ:TCRX).

What is the forecast, or price target, for Cabaletta Bio (CABA) stock?

Cabaletta Bio has a consensus price target of $24.00.

What is the current price for Cabaletta Bio (CABA)?

The stock price for Cabaletta Bio (NASDAQ: CABA) is $1.98 last updated March 12, 2025 at 7:56 PM EDT.

Does Cabaletta Bio (CABA) pay a dividend?

There are no upcoming dividends for Cabaletta Bio.

When is Cabaletta Bio (NASDAQ:CABA) reporting earnings?

Cabaletta Bio’s Q1 earnings are confirmed for Wednesday, May 14, 2025.

Is Cabaletta Bio (CABA) going to split?

There is no upcoming split for Cabaletta Bio.

What sector and industry does Cabaletta Bio (CABA) operate in?

Cabaletta Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.